Caris Life Sciences, Inc. (CAI)
NASDAQ:CAI
Want to see CAI full AI Analyst Report?
CAI Analyst Ratings
Strong Buy
9 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CAI Stock 12 Month Forecast
Average Price Target
$30.83
▲(45.77% Upside)
| Highest Price Target$38.00 | Average Price Target$30.83 | Lowest Price Target$21.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Jefferies
$28
Buy
32.39%
Upside
Initiated
04/12/26
Piper Sandler
$21
Hold
-0.71%
Downside
Initiated
04/10/26
Evercore ISI
$34→$30
Buy
41.84%
Upside
Assigned
04/06/26
Goldman Sachs
$27
Buy
27.66%
Upside
Initiated
04/01/26
Canaccord Genuity
$30→$22
Hold
4.02%
Upside
Reiterated
03/13/26
TD Cowen
$38→$35
Buy
65.48%
Upside
Reiterated
02/27/26
Robert W. Baird
$26→$28
Buy
32.39%
Upside
Reiterated
02/27/26
Citi
$42→$35
Buy
65.48%
Upside
Reiterated
02/27/26
Bank of America Securities
$35
Buy
65.48%
Upside
Reiterated
02/27/26
J.P. Morgan
$200→$35
Hold
65.48%
Upside
Reiterated
02/27/26
BTIG
$45→$38
Buy
79.67%
Upside
Reiterated
02/27/26
Wolfe Research
$32
Buy
51.30%
Upside
Initiated
07/14/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
$28
Buy
32.39%
Upside
Initiated
04/12/26
Piper Sandler
$21
Hold
-0.71%
Downside
Initiated
04/10/26
Evercore ISI
$34→$30
Buy
41.84%
Upside
Assigned
04/06/26
Goldman Sachs
$27
Buy
27.66%
Upside
Initiated
04/01/26
Canaccord Genuity
$30→$22
Hold
4.02%
Upside
Reiterated
03/13/26
TD Cowen
$38→$35
Buy
65.48%
Upside
Reiterated
02/27/26
Robert W. Baird
$26→$28
Buy
32.39%
Upside
Reiterated
02/27/26
Citi
$42→$35
Buy
65.48%
Upside
Reiterated
02/27/26
Bank of America Securities
$35
Buy
65.48%
Upside
Reiterated
02/27/26
J.P. Morgan
$200→$35
Hold
65.48%
Upside
Reiterated
02/27/26
BTIG
$45→$38
Buy
79.67%
Upside
Reiterated
02/27/26
Wolfe Research
$32
Buy
51.30%
Upside
Initiated
07/14/25
Best Analysts Covering Caris Life Sciences, Inc.
3 Months
xxx
Success Rate
2/4 ratings generated profit
Average Return
-6.10%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -6.10% per trade.
1 Year
Success Rate
2/6 ratings generated profit
Average Return
-19.52%
assigned a buy rating 13 days ago
Copying Vijay Kumar's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -19.52% per trade.
2 Years
xxx
Success Rate
2/6 ratings generated profit
Average Return
-16.57%
assigned a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -16.57% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CAI Analyst Recommendation Trends
Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
4
4
7
7
9
Buy
5
6
15
13
13
Hold
21
19
50
53
60
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
30
29
72
73
82
Each month's total comprises the sum of three months' worth of ratings.
CAI Financial Forecast
CAI Stock Forecast FAQ
What is CAI’s average 12-month price target, according to analysts?
Based on analyst ratings, Caris Life Sciences, Inc.’s 12-month average price target is 30.83.
What is CAI’s upside potential, based on the analysts’ average price target?
Caris Life Sciences, Inc. has 45.77% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CAI a Buy, Sell or Hold?
Caris Life Sciences, Inc. has a consensus rating of Strong Buy which is based on 9 buy ratings, 3 hold ratings and 0 sell ratings.
What is Caris Life Sciences, Inc.’s price target?
The average price target for Caris Life Sciences, Inc. is 30.83. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $38.00 ,the lowest forecast is $21.00. The average price target represents 45.77% Increase from the current price of $21.15.
The highest analyst price target is $38.00 ,the lowest forecast is $21.00. The average price target represents 45.77% Increase from the current price of $21.15.
What do analysts say about Caris Life Sciences, Inc.?
Caris Life Sciences, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of CAI?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.